Diabetes 2026: Rethinking Everything We Thought We Knew (Manchester)

FACE TO FACE EVENT

THIS EVENT IS OPEN TO UK REGISTERED HEALTHCARE PROFESSIONALS ONLY

Location: Royal Nawaab Stockport

One Day. Four Practice-Changing Sessions. The Future of Diabetes Care.

Getting the Diagnosis Right • Goodbye Prediabetes • Changing the Trajectory of Type 1 Diabetes • World-Class Type 2 Diabetes Management

Presenter: Professor Saqib Mahmud FRCP (Edin), FRCP (Glasg), FRCP (London), FRCGP – Award-Winning Diabetes Educator & International Speaker.

Presenter: Dr Mohamed Elnaggar MD, PhD, MRCP — Endocrinologist/Diabetologist. Lipid Service Lead at UHMBT and Clinical Lipid Lead for South Cumbria & Lancashire, specialising in lipid-lowering therapies and cardiometabolic prevention.

Event Agenda

Learning Outcomes

1. Getting the Diagnosis Right

Why Correct Classification Changes Everything

• Distinguishing Type 1, Type 2, LADA and MODY
• Recognising diagnostic pitfalls in primary care
• Understanding HbA1c limitations and hidden diabetes
• Knowing when to use C-peptide and antibody testing
• Learning from real-world cases of diabetes misdiagnosis

Key message: “The wrong diagnosis leads to the wrong treatment.”

2. Goodbye Prediabetes

Non-Diabetic Hyperglycaemia, Dysglycaemia & the New Metabolic Continuum

• Has the term “prediabetes” misled clinicians?
• Is diabetes actually a three-stage disease?
• Why cardiovascular risk begins years before diagnosis
• Understanding insulin resistance, visceral adiposity and inflammation
• The emerging concept of Stage 1, Stage 2 and Stage 3 diabetes
• Early intervention and disease modification

Key message:“By the time glucose rises, the metabolic iceberg has already formed.”

3. Changing the Trajectory of Type 1 Diabetes

The New Era of Prevention, Prediction & Precision Care

• Identifying high-risk individuals before symptoms develop
• Autoantibody screening and risk stratification
• New therapies delaying progression of Type 1 diabetes
• Advances in CGM and hybrid closed-loop systems
• Practical implications for primary care
• The future of disease interception

Key message: “The future of Type 1 diabetes is not just treatment—it is prevention.”

4. World-Class Type 2 Diabetes Management

Translating Evidence into Better Outcomes

• Individualising HbA1c targets
• Weight-centric management
• Modern use of GLP-1 receptor agonists
• SGLT2 inhibitors beyond glucose lowering
• Cardio-renal-metabolic protection
• Avoiding therapeutic inertia
• Practical insulin initiation made simple
• Real-world case studies

The Traffic System of Modern Diabetes Therapy

• 🚦 GLP-1 RA – Reduce the Input
• 🚦 Insulin – Control the Distribution
• 🚦 SGLT2 Inhibitors – Create an Exit Route

Key message: “Reduce the input. Control the distribution. Create an exit route.”

Additional Information

• This is a face-to-face, CPD-accredited event.
• A certificate of attendance will be issued for full participation.
• Suitable for GPs, prescribing pharmacists, nurses, and wider primary care MDT members.

Meet the Speakers

Professor Saqib Mahmud

FRCP (Edin) FRCP (Glasg) FRCP (London) FRCGP

Professor Saqib Mahmud specialises in all aspects of diabetes with its complexities and co-morbidities. He is passionate about preventing diabetes associated complications and prevention of strokes and heart attacks by early intervention in diabetes and providing a legacy effect which will prevent complications in the future. Diabetes lead at his practice since 2005, he has spent 15 years raising clinical standards, teaching healthcare professionals and junior doctors, and refining his expertise at international congresses. He also serves as a certified diabetes educator and Early Action in Diabetes UK champion

Dr Mohamed Elnaggar

MD, MSc, PhD, MRCP London, MRCP Endo Endocrinologist/Diabetologist SCOPE certified for Obesity Management. Acute Medicine Consultant

Dr Elnaggar earned his medical degree and completed his residency in Diabetes and Lipidology at Alexandria Faculty of Medicine, Egypt,where he also taught and conducted research as a lecturer. Since moving to the UK, he has established and now leads the Lipid Service at UHMBT, and was recently appointed Clinical Lipid Lead for South Cumbria and Lancashire.He drives the development of local lipid-management pathways and guidelines, acts as Principal Investigator in multiple clinical trials, and is a regular speaker at local, national, and international events. His work focuses on emerging lipid-lowering therapies, cardiometabolic disease prevention, and education for prescribers.